glp-1 news today 2025 october 9 Alarming rise in weight loss drug overdoses The GLP-1 Revolution Continues

This accessibility allows patients to sustain treatment long-term while implementing lifestyle strategies that maximize both fat loss and skin health outcomes

Larger Phase III trials with liver-associated histological endpoints are needed to establish the therapeutic role of incretins for NAFLD/NASH

Tirzepatide doses range from 2.5 mg to 15 mg

The nuance matters because blanket avoidance based on misunderstanding the boxed warning means missing out on a medication that could significantly benefit metabolic health

Speaking specifically to the PECs March 9 vote before the counter-offer was made, McKeever said, Were not in favor of the decision a small group of leaders across the city had made, as it relates to the PEC. Theyre taking a hard line against the mayor and refusing to open the contract, McKeever said